DERM - might go even higher - cash alone $13 .. here is i found from Twitter
Dan Rosenblum ?@sharkbiotech $DERM has $13 per share in cash a drug in front of FDA waiting approval and another in phase 2b trials data early next year its a buy in the single digitis
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.